Increasing deaths from opioid analgesics in the United States

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 9, 2006, Pages 618-627

  Paulozzi, Leonard J ^a   Budnitz, Daniel S ^b   Xi, Yongli ^a  

^a NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Analgesic; Fentanyl; Methadone; Mortality; Narcotic; Opioid; Oxycodone; Poisoning

Indexed keywords

COCAINE; CODEINE; DIAMORPHINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PETHIDINE;

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DEATH CERTIFICATE; DRUG INTOXICATION; DRUG MARKETING; EPIDEMIC; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; SUICIDE; TREND STUDY; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANALGESICS, OPIOID; HUMANS; MORTALITY; POISONING; UNITED STATES;

EID: 33748776537     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1276     Document Type: Article

References (54)

1. Fingerhut LA, Cox CS. Poisoning mortality, 1985-1995. Pub Health Rep 1998; 113: 218-233.
2. Centers for Disease Control and Prevention. Unintentional and undetermined poisoning deaths - 11 states, 1990-2001. MMWR 2004; 53: 233-238.
3. Sanford C. Deaths from unintentional drug overdoses in North Carolina, 1997-2001: A DHHS investigation into unintentional poisoning-related deaths. Available at: http://www.dhhs.state.nc.us [Accessed 6 July, 2004].
4. Landen MG, Castle S, Nolte KB, et al. Methodological issues in the surveillance of poisoning, illicit drug overdose, and heroin overdose deaths in New Mexico. Am J Epidemiol. 2003; 157: 273-278.
5. Sorg MH, Greenwald M. Maine drug-related mortality patterns: 1997-2002. Available at: http://www.state.me.us/ag/pr/drugreport.pdf [Accessed 13 August, 2004].
6. Centers for Disease Control and Prevention. Unintentional opiate overdose deaths - King County, Washington, 1990-1999. MMWR 2000; 49: 636-640.
7. Centers for Disease Control and Prevention. Increase in poisoning deaths caused by non-illicit drugs - Utah, 1991-2003. MMWR 2005; 54: 33-36.
8. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 1986; 25: 171-186.
9. Friedman DP. Perspectives on the medical use of drugs of abuse. J Pain Symp Manage 1990; 5: S2-S5.
10. Melzack R. The tragedy of needless pain. Sci Amer 1990; 262: 27-33.
11. Hill CS. Influence of regulatory agencies on the treatment of pain and standards of medical practice for the use of narcotics. Pain Digest. 1991; 1: 7-12.
12. Lamberg L. New guidelines for managing chronic pain in older persons. JAMA 1998; 280: 311-312.
13. American Academy of Pain Medicine and American Pain Society. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997; 13: 6-8.
14. American Society of Anesthesiologists. Practice guidelines for chronic pain management: a report of the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Anesthesiol 1997; 86: 995-1004.
15. Institute of Medicine. Approaching death: Improving care at the end of life - a report of the Institute of Medicine. Health Serv Res 1998; 33: 1-3.
16. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283: 1710-1714.
17. Novak S, Nemeth WC, Lawson KA. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 2004; 5: 59-65.
18. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symp Manage 2004; 28: 176-188.
19. Schumacher MA, Basbaum AI, Way WL: Opioid analgesics and antagonists. In Basic and Clinical Pharmacology, Katzung BE (ed.). Lange Medical Books: New York, NY, 2004: 497-516.
20. Stephens B, Jentzen J, Karch S, Wetli C, Mash D. National Association of Medical Examiners Position Paper on the certification of cocaine-related deaths. Am J Foren Med Pathol 2004; 25: 11-13.
21. World Health Organization (WHO). Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 9th Revision. World Health Organization: Geneva, Switzerland, 1977.
22. World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems, 10th Revision. WHO: Geneva, Switzerland, 1992.
23. Centers for Disease Control and Prevention. Public Use Data File Documentation: Multiple Cause of Death for ICD-10 2002 Data. National Center for Health Statistics: Hyattsville, MD, 2004.
24. US Department of Justice (USDOJ). Drug Enforcement Administration. ARCOS: Automation of Reports and Consolidated Orders System. Available at: http://www.deadiversion.usdoj.gov/arcos/index.html [Accessed 27 March, 2005].
25. Gammaitoni AR, Fine P, Alvarez N, McPherson M, Bergmark S. Clinical application of opioid equianalgesic data. Clin J Pain. 2003; 19: 286-297.
26. US Department of Health and Human Services (USDHHS), Substance Abuse and Mental Health Services Administration, Office of Applied Studies, and Drug Abuse Warning Network. Mortality data from the Drug Abuse Warning Network, 2002. Available at: http://DAWNinfo.samhsa.gov/ old_dawn/pubs_94_02/mepubs/default.asp [Accessed 16 December, 2004].
27. US Department of Health and Human Services (USDHHS), Substance Abuse and Mental Health Services Administration, Office of Applied Studies, and Drug Abuse Warning Network. The DAWN Report - trends in drug-related emergency department visits, 1994-2002 at a glance. Available at: http:// dawninfo.samhsa.gov/old_dawn/pubs_94_02/shortreports/files/ DAWN_EDvisits_glance.pdf [Accessed 17 December, 2004].
28. US Department of Health and Human Services (USDHHS) Substance Abuse and Mental Health Services Administration Office of Applied Studies Drug and Alcohol Services Information System. The DASIS Report - treatment admissions in urban and rural areas involving abuse of narcotic painkillers: 2002 update. Available at: www.oas.samhsa.gov/2k4/ rural-PainTX/ruralPainTX.pdf [Accessed 17 December, 2004].
29. US Department of Health and Human Services (USDHHS) Substance Abuse and Mental Health Services Administration Office of Applied Studies. Results from the 2002 National Survey on Drug Use and Health: national findings. Available at: www.oas.samhsa.gov/nhsda/2k2nsduh/Results/2k2Results.htm [Accessed 17 December, 2004].
30. International Narcotics Control Board. Narcotic drugs, estimated world requirements for 2005 - statistics for 2003. United Nations: New York, NY, 2004. Report No. E/F/S.05.XI.7.
31. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alc Depend 2003; 69: 215-232.
32. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alc Depend 2006; 81: 103-107.
33. Ballesteros MF, Budnitz DS, Sanford CP, Gilchrist J, Agyekum GA, Butts J. Increase in deaths due to methadone in North Carolina. JAMA. 2003; 290: 40.
34. Center for Substance Abuse Treatment. Methadone-associated mortality: Report of a national assessment. Rockville, MD: substance abuse and mental health services administration; 2003. Report No. 04-3904.
35. Elliott AM, Smith KI, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet. 1999; 354: 1248-1252.
36. Kallan JE. Drug abuse-related mortality in the United States: patterns and correlates. Am J Drug Alc Abuse 1998; 24: 103-117.
37. Yeadon M, Kitchen I. Opioids and respiration. Prog Neurobiol 1989; 33: 1-16.
38. Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther Drug Monit 2002; 24: 457-470.
39. Kuhlman JJ, McCaulley R, Valouch TJ, Behonick GS. Fentanyl use, misuse, and abuse: A summary of 23 postmortem cases. J Anal Toxicol 2003; 27: 499-504.
40. Saarialho-Kere U, Mattila MJ, Seppala T. Psychomotor, respiratory, and neuroendocrinological effects of a mu-opioid receptor agonist (oxycodone) in healthy volunteers. Pharm Toxicol 1989; 65: 252-257.
41. Olkkala KT, Hamenen K, Seppala T, Maunuksela EL. Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children. Br J Clin Pharmacol 1994; 38: 71-76.
42. Sajan A, Corneil T, Grzybowski S. The street value of prescription drugs. Can Med Assoc J 1998; 159: 139-142.
43. US Department of Justice (USDOJ), Drug Enforcement Administration. Drug intelligence brief-OxyContin: pharmaceutical diversion. Available at: http://www.usdoj.gov/dea/pubs/intel/02017/02017.html [Accessed 17 December, 2004].
44. Forman RF. Availability of opioids on the internet. JAMA 2003; 290: 889.
45. Harris G. Two agencies to fight online narcotics sales. New York Times October 18, 2003: 1.
46. Cone EJ, Fant RV, Rohay JM, et al. Oxycodone involvement in drug abuse deaths. A DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1,000 cases. J Anal Toxicol 2003; 27: 57-67.
47. Centers for Disease Control and Prevention. Web-based Injury Statistics Query and Reporting System (WISQARS) [Online]. (2003) National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (producer). Available at: www.cdc.gov/ncipc/wisqars [Accessed 22 March, 2005].
48. Roche T. The potent perils of a new drug. Time Magazine January 8, 2001: 47.
49. Clines F, Meier B. Cancer painkillers pose new abuse threat. The New York Times. February 9, 2001: A1.
50. White J. Virginia police fear rise of new drug. The Washington Post. February 10, 2001: B2.
51. Anderson R, Minino A, Fingerhut L, Warner M, Heinen M. Deaths: injuries, 2001. National vital statistics reports 2004; 52: 1-88.
52. Pollock DA, Holmgreen P, Lui K, Kirk ML. Discrepancies in the reported frequency of cocaine-related deaths, United States, 1983 through 1988. JAMA 1991; 266: 2233-2237.
53. Food and Drug Administration (FDA). DrugsΦDA. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ [Accessed 29 April, 2004].
54. Bowman R. Prescription for crime. Time Magazine March 28, 2005: 50-51.